Hitting Where It Hurts: Exploiting Cancer Cell 'Addiction' May Lead To New Therapies
Date: 8.6.2009
A new study uncovers a **gene expression** signature that reliably identifies cancer cells whose survival is dependent on a common signaling pathway, even when the cells contain multiple other genetic abnormalities. The research, published by Cell Press in the June 2nd issue of the journal **Cancer Cell**, identifies critical molecular vulnerabilities, thereby revealing promising therapeutic targets for a common and notoriously **treatment resistant cancer**.
Whole article on "Cell":[ http://www.cell.com/cellpress]
